127 related articles for article (PubMed ID: 34060966)
1. A technical and clinical evaluation of the new ThermoFisher BRAHMS unconjugated estriol and inhibin-A assays and their use in second trimester Down syndrome screening.
Sahota DS; Tsang FHK; Gu JS; Fung WKV; Mok KY; Wong CL
Scand J Clin Lab Invest; 2021 Sep; 81(5):371-378. PubMed ID: 34060966
[TBL] [Abstract][Full Text] [Related]
2. A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screening.
Wilson G; Liitti P; Pölönen T; Sairanen M; Spencer K
Clin Chem Lab Med; 2016 Sep; 54(9):1473-9. PubMed ID: 26887039
[TBL] [Abstract][Full Text] [Related]
3. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
4. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.
MacRae AR; Gardner HA; Allen LC; Tokmakejian S; Lepage N
Clin Chem; 2003 Jan; 49(1):69-76. PubMed ID: 12507962
[TBL] [Abstract][Full Text] [Related]
5. Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies.
Wenstrom KD; Owen J; Chu DC; Boots L
Am J Obstet Gynecol; 1997 Nov; 177(5):992-6. PubMed ID: 9396881
[TBL] [Abstract][Full Text] [Related]
6. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
7. Multiple marker second trimester serum screening for pre-eclampsia.
Wald NJ; Morris JK
J Med Screen; 2001; 8(2):65-8. PubMed ID: 11480445
[TBL] [Abstract][Full Text] [Related]
8. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
10. Appropriate biochemical parameters in first-trimester screening for Down syndrome.
Cuckle HS; van Lith JM
Prenat Diagn; 1999 Jun; 19(6):505-12. PubMed ID: 10416963
[TBL] [Abstract][Full Text] [Related]
11. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
12. Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening.
Lambert-Messerlian GM; Bestwick JP; Wald NJ
J Med Screen; 2023 Sep; 30(3):120-124. PubMed ID: 36916161
[TBL] [Abstract][Full Text] [Related]
13. Stability of inhibin A and unconjugated oestriol in the second trimester of pregnancy.
Brown LF; Shearing CH; Tydeman G
Ann Clin Biochem; 2011 Jan; 48(Pt 1):72-4. PubMed ID: 21115569
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
15. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome.
Kim SY; Kim SK; Lee JS; Kim IK; Lee K
Yonsei Med J; 2000 Apr; 41(2):226-9. PubMed ID: 10817024
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
Cuckle HS; Holding S; Jones R
Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963
[TBL] [Abstract][Full Text] [Related]
17. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
Wald NJ; Watt HC; Hackshaw AK
N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
[TBL] [Abstract][Full Text] [Related]
18. Impact of Unconjugated estriol (uE3) assay interference on prenatal screening tests.
Wyness SP; Snow TM; Villanueva M; Kunzler T; Seiter J; Genzen JR; Johnson LM
Clin Chim Acta; 2022 Nov; 536():1-5. PubMed ID: 36096208
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.
Wang YY; Luo J; Zhu MW; Liu LN; Ma X
Int J Gynaecol Obstet; 2006 Jul; 94(1):67-72. PubMed ID: 16806218
[TBL] [Abstract][Full Text] [Related]
20. Screening for Down syndrome at 14 weeks of pregnancy.
Wald NJ; Watt HC; Haddow JE; Knight GJ
Prenat Diagn; 1998 Mar; 18(3):291-3. PubMed ID: 9556047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
